Mark Rothera
Signal active
President and CEO
Contact Information
Social
Primary Organization
Viracta Therapeutics
Founded
2007
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma, Therapeutics, Oncology
Bio
Mark Rothera is the President and CEO of Viracta Therapeutics. He previously worked at Silence Therapeutics as a President and CEO. Mark Rothera attended the University of Cambridge.
Location
Summit, New Jersey, United States, North America
Jobs history
3
Genpharm
Board Member
2020 - Current
Viracta Therapeutics
President and CEO
2022 - Current
Silence Therapeutics
President and CEO
2020 - 2022
Educations
2
INSEAD
Marketing
University of Cambridge
Natural Sciences
Profile Resume
Mark Rothera is the President and CEO at Viracta Therapeutics, based in United States, North America. With a background in Biotechnology, Mark Rothera has a rich history of leadership and innovation.Mark Rothera studied MBA Marketing at INSEAD. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.